# Vext Science, Inc. (VEXTF)

> Healthcare · CA · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VEXTF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 23.81M | $ -1.19M | $ 948.0K | $ 33.73M | $ 54.11M |
| 2025 | $ 52.81M | $ -18.59M | $ 8.38M | $ 34.97M | $ 55.27M |
| 2024 | $ 37.80M | $ -23.55M | $ 1.92M | $ 39.52M | $ 75.74M |
| 2023 | $ 37.89M | $ 4.76M | $ 1.81M | $ 36.41M | $ 94.50M |
| 2022 | $ 39.56M | $ 13.54M | $ -3.28M | $ 38.15M | $ 71.92M |
| 2021 | $ 44.27M | $ 5.93M | $ -8.44M | $ 14.10M | $ 59.39M |
| 2020 | $ 32.10M | $ 2.71M | $ -1.23M | $ 11.49M | $ 36.31M |
| 2019 | $ 28.81M | $ 3.61M | $ -4.02M | $ 7.29M | $ 25.67M |
| 2018 | $ 24.40M | $ 4.95M | $ 1.04M | $ 1.26M | $ 17.00M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.62 |
| Liabilities / Eq | 1.16 |
| Current Ratio | 0.97 |

## Other views

- [Metrics](https://sponda.capital/en/VEXTF.md)
- [Charts](https://sponda.capital/en/VEXTF/charts.md)
- [Compare](https://sponda.capital/en/VEXTF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.